Amylin Pharmaceuticals
Lua error in package.lua at line 80: module 'strict' not found.
 |
|
| Private | |
| Industry | Biotechnology |
| Founded | 1987 |
| Headquarters | San Diego, California, USA |
|
Key people
|
Daniel M. Bradbury[1] |
| Products | Symlin (pramlintide) Byetta (exenatide) |
| Revenue |  US$758M (FY 2009)[2] |
 US$-173M (FY 2009)[2] |
|
| US$-186M (FY 2009)[2] |
|
| Total assets | US$1.73B (FY 2009)[3] |
| Total equity | US$423M (FY 2009)[3] |
|
Number of employees
|
1,900 [1] |
| Slogan | Challenging Science, Changing Lives. |
| Website | www.amylin.com |
Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended-release). On February 4, 2014, the U.S. FDA approved Myalept (metreleptin), an analog of human leptin,[4] as replacement therapy to treat the complications of leptin deficiency, in addition to diet, in patients with congenital generalized or acquired generalized lipodystrophy.[5]
In July 2012, Bristol-Myers Squibb announced it would acquire Amylin Pharmaceuticals for $5.3 billion.[6]
In December 2013, Amylin was acquired by AstraZeneca.[7]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 2.0 2.1 2.2 Amylin Pharmaceuticals (AMLN) annual SEC income statement filing via Wikinvest.
- ↑ 3.0 3.1 Amylin Pharmaceuticals (AMLN) annual SEC balance sheet filing via Wikinvest.
- ↑ Lipodystrophy Orphan Drug Program. Amylin Pharmaceuticals.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
